Ribonuclease L (RNase L) is an intracellular enzyme that is vital in innate immunity, but also is a tumor suppressor candidate. Here, we show that overexpression of RNase L decreases cellular growth and downmodulates the RNAbinding protein, HuR, a regulator of cell-cycle progression and tumorigenesis. The effect is temporal, occurring in specific cell-cycle phases and correlated with the cytoplasmic localization of RNase L. Both cellular growth and HuR were increased in RNASEL-null mouse fibroblast lines when compared to wild-type cells. Moreover, the stability of HuR mRNA was enhanced in RNASEL-null cells. The HuR 3 0 untranslated region (UTR), which harbors U-rich and adenylate-uridylate-rich elements, was potently responsive to RNase L when compared to control 3 0 UTR. Our results may offer a new explanation to the tumor suppressor function of RNase L.
Introduction
Ribonuclease L (RNase L) is an intracellular endoribonuclease that has been suggested as a tumor suppressor candidate due to linkage with hereditary prostate cancer (HPC1) gene and because of its proapoptotic role (Zhou et al., 1998; Carpten et al., 2002; Silverman, 2003) . The mechanism of RNase L on cell division is not known. Classically, many tumor suppressors, such as p53, halt cell-cycle progression by regulating cell-cycle check points governed by cyclins and cyclin-dependent kinases. But there are proteins of different functional classes that affect these activities such as the RNA-binding protein, HuR, a member of mammalian homologues of embryonic lethal abnormal vision (ELAV) proteins comprising a group of RNA-binding proteins first described in Drosophila. HuR is implicated in the stabilization of several adenylate uridylate (AU)-rich mRNAs including those that regulate the cell cycle such as cyclins A and B, and p21, and those that affect tumor activities such as urokinase activator (uPA) and cyclooxygenase, COX-2 (Wang et al., 2000 (Wang et al., , 2001 Subbaramaiah et al., 2003; Tran et al., 2003) . Knockout of HuR by siRNA or antisense vectors decreases cellular growth (Lopez de Silanes et al., 2003; Dormoy-Raclet et al., 2007) .
RNase L is activated by 2 0 ,5 0 -oligoadenylates (2-5A), which are synthesized from ATP by the 2 0 ,5 0 -oligoadenylate synthetase (OAS), an interferon (IFN)-inducible gene product. OAS itself is expressed as a latent protein that is active on binding to double-stranded RNA. The latter is produced as an intermediate during the viral life cycle (Stark et al., 1998) or possibly due to cellular RNA with double-stranded structures (Wang and Carmichael, 2004; Molinaro et al., 2006) . RNase L has been known for its involvement in the defense against viruses due to its potent degrading effect on viral mRNAs (Kumar et al., 1988; Zhou et al., 1997 Zhou et al., , 1998 Li et al., 1998; Khabar et al., 2000) . Moreover, it has been shown that prostate cancer subjects with mutations in RNASEL are more susceptible to infection by a novel gammaretrovirus (Urisman et al., 2006) . RNase L, itself, does not cause global degradation of cellular mRNA in intact cells due to the low endogenous levels of 2-5A. Rather, 2-5A at high concentrations leads to degradation of ribosomal RNA, such as those encountered during acute viral replication or when exogenously added to cells (Wreschner et al., 1981a; Cirino et al., 1997; Li et al., 1998) . Previously, we were able to provide the first evidence that RNase L, in the absence of viral infection, can act on cellular mRNAs (Khabar et al., 1999 . Specifically, RNase L downregulates the double-stranded RNA-dependent protein kinase (PKR) mRNA and subsequently leads to downregulation of the consequences of this effect, that is, eIF2a phosphorylation and inhibition of protein synthesis . Here, our findings revealed that RNase L downmodulates HuR mRNA and subsequently HuR protein in a manner that is correlated with RNase-L-induced suppression of cellular growth and cytoplasmic localization of RNase L.
Results

Moderate overexpression of RNase L and effects on cellular growth
To elucidate the mechanism of the cell growth suppressor action of RNase L, we generated a polyclonal cell line from a HeLa line-with undetectable or very low expression of RNase L-that stably expresses moderate amounts of RNase L. Approximately twofold expression in RNase L at the protein level when compared to vector was achieved (Supplementary Figure 1) . We chose a short-term polyclonal line generation approach in contrast to monoclonal lines to avoid cell selection bias as subtle variations in RNase L can lead to significant changes in mRNA levels.
We used a new continuous real-time biosensor that measures cellular growth based on impedance (Solly et al., 2004; Zhu et al., 2006) , to assess the effect of RNase L expression. The RNase-L-expressing cell line had reduced growth rates when compared to the control cell line and was more pronounced when cells were approaching confluence (Figure 1a) . These results were similar when a colorimetric conventional assay (Alamar blue) was used (data not shown). The antiproliferative effect observed was not due to apoptosis as the proapoptotic effect of RNase L requires an apoptosis inducer (Diaz-Guerra et al., 1997; Zhou et al., 1997; Castelli et al., 1998) , which was not used in this study. Also, flow cytometry analysis that measures DNA content of sub-G 1 cells showed there was no difference in the percentage of apoptotic cells; o3% of the total cell pool in both vector and RNase-L-expressing cell lines.
Cellular mRNA changes due to RNase L To find which gene products affect cellular growth and are modulated by RNase L, we used custom-made microarrays (Frevel et al., 2003; Khabar et al., 2004) that contain probes for U-rich mRNAs-RNase L is known to cleave at U-rich dinucleotides (Wreschner et al., 1981b) . Comparing microarray gene expression patterns from cells expressing RNase L with control vector revealed that the mRNA levels of the RNAbinding protein, HuR, were reduced in RNase L HeLaexpressing cells (Figure 1b ). In addition, two known mRNA targets for HuR, urokinase plasminogen activator (uPA) and cyclin D1 (Tran et al., 2003; Lal et al., 2004) , were reduced in RNase-L-expressing HeLa cells. As a control, HeLa cells overexpressing HuR (Figure 1b , inset blot) have increased uPA and cyclin D1 mRNA levels in the same cell type (Figure 1b) . Because the microarray data were for screening purposes, we further focused on HuR rather than gene expression patterns of the individual genes in the array data. Semiquantitative RT-PCR experiments confirmed that RNase L led to reduction in HuR mRNA levels ( Figure 1c) . To confirm the findings that RNase L led to HuR downregulation, we measured levels of HuR protein by western blotting. Levels of HuR protein were reduced (B2-fold reduction, Po0.01) in RNase-Lexpressing cells when compared to control cells (Figure 1d ).
Effect of RNase L and HuR knockdown on HuR protein and cellular growth Further, we used mouse embryonic fibroblast (MEFs) lines generated from RNASEL-knockout and wild-type mice (Zhou et al., 1997) . Western blotting confirmed the absence of RNase L using anti-mouse RNase L antibody ( Figure 2a ). Increased HuR levels (2.5-fold, HuR was upregulated in wild-type and RNASELknockout MEFs both in confluent and subconfluent MEFs due to continuous absence of RNase L (Supplementary Figure 2 ). The RNASEL-null MEFs had increased growth rates compared to the wild-type cells (Figure 2c ). Doubling times indicated that RNASELnull cells divide 2.7-fold faster than wild-type cells (Po0.001).
To examine the impact of HuR knockdown on RNase-L-induced antiproliferative action, we first evaluated silencing experiments with several short-hairpin (shRNA) vectors against HuR or control sequence (Supplementary Figure 3) in HEK293 cells. The most effective shRNA against HuR, which gave approximately 95% knockdown at 20 h after transfection, was used (clone 4; Supplementary Figure 3 ). HuR-knockdown cells were further transiently expressed with RNase L expression vector or control vector and monitored for cellular growth. RNase L fails to cause antiproliferative action in HuR-silenced cells but was effective in the control (negative) shRNA-expressed cells ( Figure 2d ).
RNase L modulation of HuR mRNA
It was not possible to assess the mRNA half-life in RNase-L-expressing cells due to the low levels of HuR; thus, we used the RNASEL-knockout MEF lines. Experiments were performed with semi-quantitative PCR; the one-phase exponential decay model using b-actin-normalized signals was used. The HuR mRNA stability was enhanced in the RNASEL-null fibroblasts. The half-life of HuR mRNA in wild-type fibroblasts was 1.5 h in contrast to more than 6 h in RNASEL-knockout cells (Figures 3a and b) . Figure 3a also confirmed that RNase L deficiency led to increased HuR mRNA levels (levels at 0 h).
We have fused two 3 0 untranslated regions (UTR) that contain U-rich/ARE-like sequence and ARE ( Figure 4a ) to enhanced green fluorescent protein (EGFP) coding region as a reporter expression system ( Figure 4b ). The half-life of the reporter GFP mRNA was measured by real-time RT-PCR in the mouse fibroblasts transfected with the different reporters. The half-life of GFP mRNA (T 1/2 ¼ 0.5 h) expressed from the reporter construct with the AREcontaining HuR 3 0 UTR was significantly (Po0.01) shorter than the half-life of the GFP mRNA (T 1/2 ¼ 1 h) expressed from the control 3 0 UTR (Figure 4c) . Further, the half-life of GFP mRNA expressed from the AREbearing HuR 3 0 UTRs was longer by twofold in RNASEL-null fibroblasts when compared to wild-type cells (Figure 4c) .
Further, we used reporter fluorescence readout in the RNase-L-expressing polyclonal cells, because with the embryonic fibroblasts, it was difficult to visualize and quantify fluorescence levels. The ARE-containing HuR 3 0 UTR itself caused reduction (threefold, Po0.001; Student's t-test) of reporter activity when compared to the control 3 0 UTR (Figure 4d ). Though RNase L caused reduction of reporter fluorescence from the construct with the control 3 0 UTR, due to the RNase L suppression of cellular growth-to demonstrate this effect we preferred not to normalize these experimentsit was far more potent toward the HuR 3 0 UTR and on uPA ARE-containing 3 0 UTR (Figure 4d ). RNase L was able to potently (Bonferroni test for each of the column pair against control was o0.001) downregulate fluorescence activity from fusion RNAs containing HuR 3 0 UTRs with both ARE-like and ARE regions by at least threefold ( Figure 4d ) when compared to the control 3 0 UTR (Po0.001).
These data suggest that RNase L may generally act on U-rich element containing sequences. A reverse transcription (RT)-PCR using specific primers to HuR mRNA was performed on IP RNA obtained after antiRNase L (data not shown); RNase L did not appear to bind HuR mRNA directly and thus may require other interacting partners. Dependence of RNase L activity on confluency, cell cycle and nuclear/cytoplasmic distribution The effect of RNase L on cellular growth appeared to be greater in confluent cells when compared to subconfluent cells (Figures 1a and 2c) . Likewise, the effect of RNase L on HuR levels was greater in confluent cells when compared to subconfluent cells (Figure 5a) . As a result, we did not observe consistently an effect of RNase L on HuR levels with subconfluent cells. To determine if the effect was dependent on cell cycle, the RNase-L-expressing HeLa cells were synchronized in late G 1 with G 1 /S arrest using a starvation/aphidocholin treatment regimen. Flow cytometry data showed that the cells were indeed 75% in G 1 phase and most of the HuR was cytoplasmic. HuR was dramatically reduced in RNase-L-expressing cells at the G 1 /S transition (Figure 5b ). In contrast, when G 1 /S-arrested cells were released by trypsinizing the cells and then subculturing them to S phase, there was no effect of RNase L on HuR protein (Figure 5b ). In this case, HuR was nuclear. Likewise, asynchronized cells or cells in phases where HuR is predominately nuclear, the effect of RNase L was negligible (data not shown). These data suggest that the effect of RNase L on HuR occurs when cell conditions favor cytoplasmic localization of HuR. Indeed, kinetics experiments of HuR translocation monitored by both confocal microscopy and flow cytometry showed that HuR cytoplasmic localization was dependent on cell-cycle phase (Supplementary  Figure 4) . þ / þ mouse embryonic fibroblasts (MEFs) were treated with medium control (0 time point) or actinomycin D (5 ug/ml) for various times, as indicated. The b-actin-normalized mRNA levels were quantified by real-time PCR using TaqMan primers/probe specific to EGFP and b-actin as described in Materials and methods. The reference point was 100% of control (time 0, RNase L þ / þ ). Half-life determinations were assessed using one-phase exponential decay model as described in Materials and methods. Data are from two independent experiments. (d) Cell lines stably expressing RNase L/neo and vector/neo in 96-well plates were transfected with the different 3 0 -UTR constructs as indicated. Numbers in x axis refer to the constructs as outlined in (b). Readings are mean ± s.e.m. of fluorescence intensities from quadruplicate wells. ***P-value o0.001 with Bonferroni post-tests and two-away analysis of variance (ANOVA).
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To gain further insights to the differential effect of RNase L on HuR during confluence or cell cycle, we have looked at nuclear/cytoplasmic distribution of RNase L. Because of the low expression of RNase L in the cell line used in the previous experiments, that is, HeLa, we used Huh-7 liver cell line for the localization studies. We found that RNase L can exist in the nucleus or in the cytoplasm when cells are subconfluent or confluent (Figure 6a ). The spatial distribution of RNase L and HuR during confluent and subconfluent cell conditions was also verified by western blotting using nuclear and cytoplasmic fractions (Figure 6b ).
Because RNase L is continuously devoid in RNA-SEL-knockout MEFs, HuR upregulation should be seen in both nuclear and cytoplasmic compartments and independent on confluence. Supplemental data (Supplementary Figures 2 and 5) show this is the case.
Discussion
RNase L has an essential function in host defense, particularly against viruses including both DNA and RNA viruses Zhou et al., 1998; Khabar et al., 2000) . Further work showed that RNase L is also involved in apoptosis and in tumor suppression although without known mechanisms (Zhou et al., 1997; Castelli et al., 1998; Carpten et al., 2002; Xiang et al., 2003; Urisman et al., 2006; Andersen et al., 2007; Liu et al., 2007) . In this study, we demonstrated a probable mechanism whereby RNase L suppresses cellular growth. Briefly, we have provided evidence, using both RNase L overexpression and RNase L knockout models, that RNase-L-mediated suppression of cellular growth is associated with downregulation of the RNAbinding protein, HuR, mRNA and protein, and were grown into two different densities in six-well plates, so that confluent (100% of total well area) and subconfluent (B40%) monolayers were achieved the next day. Western blots were performed using anti-HuR and anti-b-actin. The b-actin-normalized densitometry of blots (mean ± s.e.m.) from three independent experiments are shown (lower panel). ***Po0.001 using Student's t-test. (b) Cells that stably express neomycin/vector control or RNase L/neomycin were seeded on coverslips. After 20 h, the cells were serumstarved, then treated with aphidocholin for additional 20 h to arrest cells in G 1 /S, that is, late G 1 (upper panels). Subsequently, cells were released from the arrest to enter S phase (lower panels) by removing the drug and subculturing in complete medium with 15% serum for 8 h. The fluorescently labeled secondary antibody was used to reveal anti-HuR antibody using confocal microscopy. Flow cytometry was performed by propidium iodide staining. dependent on cytoplasmic localization of RNase L. HuR stabilizes key AU-rich mRNAs involved in cellular growth (for example, cyclin D1 and c-myc) and angiogenesis/metastasis, such as uPA, COX-2 and VEGF. HuR is well known to upregulate mRNA targets important for cell proliferation and subsequently to increase cellular growth (Lopez de Silanes et al., 2003; Dormoy-Raclet et al., 2007) . Thus, we have not pursued further confirmation of the well-studied pathway of HuR effect on cellular growth. Instead, we have focused on RNase L suppression of cellular growth and correlation with HuR expression.
In this report, we found that RNase L influenced HuR mRNA expression by virtue of using microarray analysis on cells stably expressing moderate amounts of RNase L.
Although, RNase L has been primarily recognized in the past as antiviral enzyme, the data on the effect of RNase L on the mRNA stability of HuR in this study, PKR in our previous report , on MyoD by other investigators (Bisbal et al., 2000) and on ISG43 (Li et al., 2000) , clearly indicate a regulatory function on cellular mRNAs without virus activation. The mRNA for MyoD, a muscle differentiation transcriptional factor, which itself has been shown to be a target for RNase L (Bisbal et al., 2000) , was also found to be an HuR mRNA target by a previous study (van der Giessen et al., 2003) . This may indirectly support our finding of RNase L action on HuR mRNA. The HuR 3 0 UTR contains both ARE-like and ARE, which may render the HuR mRNA more susceptible to RNase L action that is known to cleave at UU or UA dinucleotides (Wreschner et al., 1981b) . The effect of RNase L on cellular mRNA is not global because many control and housekeeping mRNAs are not affected (Bisbal et al., 2000; Li et al., 2000; Khabar et al., 2003) . An intriguing question is: what is the source of doublestranded RNA, an activator of OAS, that leads to generation of 2-5A that binds and activates RNase L? The answer may be the cellular mRNAs themselves, which assume secondary RNA structures such as hairpins that can activate the OAS/RNase L. A general review of the source and fate of putative cellular double-stranded RNA is given in Wang and Carmichael (2004) . In addition, cellular mRNAs capable of activating OAS/RNase L system have been recently described Malathi et al., 2007) .
The RNase L effect appears to be associated with its cytoplasmic localization that is favored in confluent cells. It has been shown that RNase L/OAS pathway fluctuates with cell confluence (Jacobsen et al., 1983; Zhou et al., 1998) and may contribute, at least partly, to some of the observations with confluent cells. For example, levels of OAS, which is an upstream activator of the RNase L pathway, increase at confluence (Jacobsen et al., 1983) and in HeLa cells, and at G 1 /S transition in Daudi cells (Kumar et al., 1994) . In this study, we show that the requirement of confluence for the described RNase L activity paralleled the spatial distribution and localization of HuR and RNase L during cell confluence stages. Thus, it appeared that both RNase L cytoplasmic localization and activity are optimum in confluent cells or specifically at G 1 /S transition. The RNase L action on HuR mRNA is independent on IFN activity because RNase L was effective against HuR mRNA, both in the presence and absence of IFN treatment of cell culture.
HuR is a nuclear shuttling protein (Keene, 1999 ) that primarily exists in the nucleus and moves to the cytoplasm during cellular activation and stress (Gallouzi et al., 2000; Wang et al., 2000) . Previous work suggests that HuR translocation to the cytoplasm is temporal where it may regulate the stability or translation of cellcycle mRNAs (Atasoy et al., 1998) . Also, a recent study found that a target for HuR is the RNase L mRNA , indicating the possibility for reciprocal regulation of RNase-L-and HuR-mediated events. Because both HuR and RNase L localize in the nucleus during subconfluent cell stages and appear in the cytoplasmic compartment as cells grow to confluence, RNase L may actually be a shuttling protein. An earlier report showed that RNase L can exist in both cytoplasm and nucleus and this can be influenced by cell confluence (Bayard and Gabrion, 1993) . Thus, our finding of RNase L in the nucleus, despite the notion that RNase L is a cytoplasmic protein, supports this earlier report. Further details of RNase L as a shuttling protein such as presence of nuclear localization signal in RNase L will require different set of experiments.
In situations where RNase L is mutated (Urisman et al., 2006) , control of HuR expression by RNase L may also be defective. Expression of HuR and cytoplasmic localization have been shown to be increased in several tumors such as breast, colon, gastric and ovarian tumors when compared to normal tissues (Lopez de Silanes et al., 2003; Denkert et al., 2004; Heinonen et al., 2005; Mrena et al., 2005; Mazan-Mamczarz et al., 2008) . Many important mRNA targets for HuR such as cyclin D1, COX-2 and uPA, have defined functions in tumor maintenance and metastasis. In healthy cells, RNase L may act as a negative feedback mechanism for HuR expression. Deregulation of this pathway may lead to upregulation of HuR mRNA targets in which their gene products are involved in tumorpromoting events.
Materials and methods
Cell lines WISH (HeLa markers) and HeLa cell lines were obtained from American Type Culture Collection (Rockville, MD, USA) and cultured in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and antibiotics. Huh-7 was obtained from Dr Stephen Polyak (University of Washington, Seattle, WA, USA) and was propagated in Dulbecco's modified Eagle's medium (DMEM) medium with 10% FBS and antibiotics. RNase L þ / þ MEF lines were generated from C57BL/6 mice whereas RNase L À/À MEFs were generated from RNase L À/À mice on the C57BL/6 background as previously described (Zhou et al., 1997) . Immortalized post-crisis lines (10-14 passages (Zhou et al., 1997) were initially obtained by continuous culturing and propagated in DMEM with high glucose, supplemented with 10% FBS and antibiotics (Invitrogen). The passage numbers used in this study were between 30 and 37.
Transient and stable transfection of polyclonal cell lines for RNase L and HuR HeLa cells were transfected with either pcDNA3.1 vector, pcDNA3.1 containing full-length human RNase L cDNA or full-length human cDNA for HuR (kindly provided by Dr Christoph Moroni, Basel, Switzerland). Stable transfections were performed in medium without serum using Lipofectamine 2000 (Invitrogen) for 6 h, followed by replacing the medium with serum-supplemented medium. After overnight, cells were treated with neomycin (G418) until clones were formed. Approximately 50 neomycin-resistant clones were pooled as a single polyclonal line. We have used pooled populations of drug-selected clones to rule out possible clonal variations. Cells were only used for the first 20 passages that had no loss of overexpression as determined by western blotting.
RNA interference using a vector-based short-hairpin siRNA Four expression plasmids coding shRNA against HuR and a negative control shR0NA, which is a scrambled artificial sequence that does not match human genes, were obtained from Superarrays Inc. (Frederick, MD, USA). A screen for HuR knockdown efficiency was performed using HuR-GFP construct. HEK293 cells in 96-well plates were transfected with Lipofectamine 2000 with HuR-GFP and each of the four shRNA plasmids (each is 50 ng per microwell). Fluorescence levels from the transfected HuR-GFP were quantitated after 20 or 48 h and compared to levels from the cells transfected with the control negative shRNA.
Western blotting
Cells were lysed for 30 min on ice in lysing buffer that contains 10 mM Tris, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitor cocktail (Sigma, St Louis, MO, USA). Fractionation of nuclear and cytoplasm components was performed using a kit (Biochain) according to the manufacturer's instructions. Equal amounts of protein samples were subjected to electrophoresis on 10% SDS-polyacrylamide gels followed by transfer to nitrocellulose membranes (Hybond ECL; Amersham Biosciences, Little Chalfont, UK). Membranes were hybridized with primary antibody (1:500) to HuR (Santa Cruz Biotechnology, Santa Cruz, CA, USA), RNase L (1:500) or b-actin (1:1000) followed by secondary horseradish peroxidase (HRP)-conjugated antibody. The anti-mouse RNase L, which is raised in rabbits against an N-terminal peptide of mouse RNase L, was generated using custom peptide and antibody synthesis service (Alpha Diagnostics, San Antonio, TX, USA). Signal detection was performed with ECL western blotting detection reagents (Amersham Biosciences). Protein molecular weight markers were used to verify the size of the proteins.
Real-time continuous assessment of cellular growth Cellular growth of cell lines expressing RNase L or shRNA against HuR was assessed using the real-time electronic biosensor, RT-CES system (ACEA Biosciences Inc., San Diego, CA, USA). This system is described in detail elsewhere (Solly et al., 2004; Zhu et al., 2006) . Cells were seeded in a special 96-well plate and incubated in the RT-CES system incubator for 3-5 days. Data were collected every 20 min automatically by the analyser under the control of integrated software. For verification, a cellular growth curve was also obtained using colorimetric growth indicator Alamar blue (BioSource International, Camarillo, CA, USA) according to the manufacturer's instructions.
3
0 -UTR PCR, construction and cloning of reporter plasmids Regions that contain putative U-rich element sequences that correspond to the partial 3 0 UTRs of HuR (NM_00419; 1146-2359nt for U-rich ARE-like stretches, and 1146-2920nt for AREcontaining transcript; Figure 3a ) and urokinase activator (NM_002658; 2161-2301nt) were obtained by RT-PCR. Briefly, total RNA was extracted by Tri Reagent from LPS-induced THP-1 cell line. The cDNAs were amplified by PCR in which the forward primer contains BamH1 site (underlined) and the reverse primer with XbaI site (underlined) as follows-the HuR short 3 0 . The PCR products were purified, precipitated and cut by BamH1 and XbaI sequentially, and subsequently ligated into EGFP plasmid (Gene Therapy Systems Inc., San Diego, CA, USA) that is under CMV/intron A constitutive promoter. After ligation and transformation, recombinant colonies were verified by PCR using a forward vector-specific primer and 3 0 UTR or ARE reverse primer.
Reporter transfection and activity assessment Reporter constructs containing GFP-3 0 UTR/ARE were used in transient transfection at 25 ng per 2 Â 10 4 cell per well in 96-well microplates. Transfection was performed with Lipofectamine 2000 as described earlier. In co-transfection experiments, the expression plasmids of RNase L, HuR and mock (pcDNA 3.1) were kept constant at 100 ng unless otherwise indicated. Transfection efficiency and normalization to control was achieved using EGFF reporter fused with stable EEF1A1 3 0 UTR. The intrawell variance of any replicate groups in fluorescence is generally o6%, which does not warrant intrawell normalization of transfection (Al-Zoghaibi et al., 2007) . Fluorescence was quantitated using a sensitive bottom read instrument Zenyth 3100 (Anthos Labtec, Eugendorf, Austria) or by using image segmentation and quantitation algorithm (Al-Zoghaibi et al., 2007) . Data are presented as mean value ± s.e.m. of fluorescence intensity.
Confluence and flow cytometry analysis Cells were made either subconfluent or confluent by culturing the appropriate cell number overnight. Cell quiescence of normal human fibroblasts was achieved by confluence over a period of 3 days. Cell synchronization was achieved by first arresting G 0 by starvation using serum-free medium for 16 h, followed by synchronization at G 1 /S by treating cells with 5 mg/ml aphidocholin (Sigma) for 20 h. To release cells in the S phase, the cells were washed off the inhibitor and subcultured in complete medium with 15% serum. Cell phase status was monitored by flow cytometry. Cells from either subconfluent (40% of total well area) or confluent cultures were harvested by trypsinization, washed in phosphate-buffered saline (PBS) and resuspended in ice-cold fixation solution. Cell suspensions were processed for cell-cycle determination using the propidium iodide method with flow cytometry.
Immunofluorescence and confocal microscopy Cells were seeded on coverslips, mounted on slides, overnight to be subconfluent (40% of total well area) or confluent (100%) for the following day. The slides were formaldehydefixed for 15 min at 37 1C in PBS (pH 7.4), followed by permeabilization of the cellular membrane with 0.05% triton for 5 min incubation and treated with 1:50 primary antibody to HuR or RNase L for 16 h at 4 1C. The cells were then washed to remove unbound antibodies and then treated with fluorescein isothiocyanate (FITC)-labeled secondary antibody (1:200; 1 h at 37 1C). Cells were then washed in PBS and the fluorescence was analysed using confocal microscopy (LeicaKaki, Saudi Arabia). For colocalization studies, cells were treated with goat anti-HuR (1:50) and mouse anti-RNase L (1:50; C-17; Santa Cruz Biotechnology). FITC-conjugated and tetramethylrhodamine isothiocyanate (TRITC)-conjugated secondary antibodies were used for HuR and RNase L antibodies, respectively.
In the Supplemental Materials, the following methods are described:
Microarray expression and analysis Semi-quantitative and real-time RT-PCR Statistics and image analysis
